Showing 4691-4700 of 7540 results for "".
- AAD Issues Statement on Skin Cancer Screeninghttps://practicaldermatology.com/news/aad-issue-statement-on-skin-cancer-screening/2458789/Mark G. Lebwohl, MD, FAAD, President, American Academy of Dermatology issued the following statement on skin cancer screenings: “The American Academy of Dermatology believes that early detection is vital in the fight against skin cancer, the most common cancer in the United States.
- AMA Disappointed CMS Moving Ahead with Problematic Information on Website for Patientshttps://practicaldermatology.com/news/ama-disappointed-cms-moving-ahead-with-problematic-information-on-website-for-patients/2458788/The AMA is "dismayed" that CMS is moving forward with its Physician Compare website, the AMA has issued a statement to express its concern "that incomplete and potentially inaccurate information...will misinform patients." “Given the widespread accuracy issu
- Cosmetic Surgery Forum Wraps Seventh Successful Yearhttps://practicaldermatology.com/news/cosmetic-surgery-forum-wraps-seventh-successful-year/2458791/Covering topics from the appropriate use of permanent fillers to the role of spirituality in practice, the seventh annual Cosmetic Surgery Forum (CSF) brought together experts from multiple specialties at the Aria in Las Vegas this month. The three-day program included guidance on practice manage
- Rock Creek Pharmaceuticals Adds KOLs to Enhance Dermatological Disease Programhttps://practicaldermatology.com/news/rock-creek-pharmaceuticals-adds-kols-to-enhance-dermatological-disease-program/2458794/Rock Creek Pharmaceuticals, Inc., a clinical stage drug development company focused on the application of its lead compound being developed to treat chronic inflammatory conditions, has retained two Key Opinion Leaders (KOLs), each having renowned international expertise in dermatological d
- AAD Releases New App to Aid Patients with Chronic Hiveshttps://practicaldermatology.com/news/aad-releases-new-app-to-aid-patients-with-chronic-hives/2458798/The American Academy of Dermatology (AAD) released its Chronic Hives Patient App, which offers tools and resources for chronic hives management. The free mobile app, developed with a grant from Novartis Pharmaceuticals Corp., can help patients learn more about their condition, find a doctor, trac
- Brickell Secures Rights to a Novel Class of RORγ Inhibitors for Psoriasis and Other Autoimmune Diseaseshttps://practicaldermatology.com/news/brickell-biotech-secures-rights-to-a-novel-class-of-ror-inhibitors-for-psoriasis-and-other-autoimmune-diseases/2458801/Brickell Biotech, Inc. has secured the exclusive world-wide rights to a series of novel retinoic acid–related orphan nuclear receptor gamma (RORy) inhibitors from Orca Pharmaceuticals (Orca) and New York University (NYU). This chemical series is based on intellectual property emerg
- Almirall Acquires Veltin® and Altabax® from Stiefel, a GSK Companyhttps://practicaldermatology.com/news/almirall-acquires-veltin-and-altabax-from-stiefel-a-gsk-company/2458802/Almirall has acquired the rights to Veltin® and Altabax, from Stiefel, a GSK company, in exchange for distribution rights to Toctino® and an undisclosed cash payment.
- Pfizer and Allergan to Combinehttps://practicaldermatology.com/news/pfizer-and-allergan-to-combine/2458803/The boards of directors for Pfizer Inc. and Allergan plc have both unanimously approved, and the companies have entered into, a definitive merger agreement under which Pfizer will combine with Allergan in a stock transaction currently valued at $363.63 per Allergan share, for a total enterprise v
- AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Deviceshttps://practicaldermatology.com/news/ama-calls-for-ban-on-direct-to-consumer-advertising-of-prescription-drugs-and-medical-devices/2458806/Physicians at the Interim Meeting of the American Medical Association (AMA) adopted new policy aimed at driving solutions to make prescription drugs more affordable. Physicians cited concerns that a growing proliferation of ads is driving demand for expensive treatments despite the clinic
- Dr. Jennifer Nam Choi Appointed Chief of OncoDermatology for Northwestern Medicinehttps://practicaldermatology.com/news/dr-jennifer-nam-choi-appointed-chief-of-oncodermatology-for-northwestern-medicine/2458809/Jennifer Nam Choi, MD, has been named Chief of the Division of OncoDermatology at Northwestern Memorial Hospital and associate professor in the Department of Dermatology at Northwestern University Feinberg School of Medicine. Dr. Choi is an accomplished dermatologist specializing in the mana